blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4222162

EP4222162 - RECOMBINANT FUSION PROTEINS COMPRISING INTERLEUKIN- 18-BINDING PROTEIN AND ANTIGEN BINDING FRAGMENT TO SERUM ALBUMIN, AND COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.07.2023
Database last updated on 30.07.2024
FormerThe international publication has been made
Status updated on  08.04.2022
Most recent event   Tooltip01.12.2023Change: Validation statespublished on 03.01.2024  [2024/01]
01.12.2023Change - extension statespublished on 03.01.2024  [2024/01]
Applicant(s)For all designated states
Aprilbio Co., Ltd
B602, College of Biomedical Science
Kangwon National University, 1 Kangwondaehak-gil
Chuncheon-si, Gangwon-do 24341 / KR
[2023/32]
Inventor(s)01 / CHA, Sang Hoon
Chuncheon-si Gangwon-do 24318 / KR
 [2023/32]
Representative(s)König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf
Mönchenwerther Straße 11
40545 Düsseldorf / DE
[2023/32]
Application number, filing date21874697.229.09.2021
[2023/32]
WO2021IB58964
Priority number, dateKR2020012739529.09.2020         Original published format: KR 20200127395
[2023/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022070112
Date:07.04.2022
Language:EN
[2022/14]
Type: A1 Application with search report 
No.:EP4222162
Date:09.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2022 takes the place of the publication of the European patent application.
[2023/32]
Search report(s)International search report - published on:KR07.04.2022
ClassificationIPC:C07K14/00, C07K16/18, C12N15/62, A61K38/00, A61P17/06, A61P19/02, A61P29/00, A61P21/00, A61P35/00
[2023/32]
CPC:
C12N15/62 (EP); C07K14/4703 (EP,KR,US); A61P17/06 (EP,KR);
A61P19/02 (EP,KR); A61P21/00 (EP,KR); A61P29/00 (EP,KR);
A61P35/00 (EP,KR); A61P37/06 (US); C07K16/18 (EP,KR,US);
C07K16/245 (EP); C07K16/2866 (EP); A61K2039/505 (EP,KR,US);
A61K38/00 (EP,KR); C07K2317/55 (EP,KR,US); C07K2317/76 (EP,KR,US);
C07K2317/92 (EP,KR,US); C07K2317/94 (KR,US); C07K2319/21 (US);
C07K2319/31 (EP,KR,US); C07K2319/90 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/32]
TitleGerman:REKOMBINANTE FUSIONSPROTEINE MIT INTERLEUKIN-18-BINDENDEM PROTEIN UND ANTIGENBINDENDEM FRAGMENT AN SERUMALBUMIN SOWIE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON[2023/32]
English:RECOMBINANT FUSION PROTEINS COMPRISING INTERLEUKIN- 18-BINDING PROTEIN AND ANTIGEN BINDING FRAGMENT TO SERUM ALBUMIN, AND COMPOSITIONS AND USES THEREOF[2023/32]
French:PROTÉINES DE FUSION RECOMBINANTES COMPRENANT UNE PROTÉINE DE LIAISON À L'INTERLEUKINE 18 ET UN FRAGMENT DE LIAISON À L'ANTIGÈNE CONTRE L'ALBUMINE SÉRIQUE, COMPOSITIONS ET UTILISATIONS ASSOCIÉES[2023/32]
Entry into regional phase17.04.2023National basic fee paid 
17.04.2023Search fee paid 
17.04.2023Designation fee(s) paid 
17.04.2023Examination fee paid 
Examination procedure17.04.2023Examination requested  [2023/32]
22.11.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.09.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2011177065  (RUBINSTEIN MENACHEM [IL], et al) [Y] 1-6 * claims 1, 8; paragraphs [0013], [0078], [0079] *;
 [A]US8846042  (ZHOU HONGXING [US]) [A] 1-6 * the whole document *;
 [A]US2016215048  (PFEIFER ANDREA [CH], et al) [A] 1-6 * the whole document *;
 [Y]US2016376350  (CHA SANGHOON [KR]) [Y] 1-6 * claims 1, 8, 9; paragraph [0076]; figure 22a *;
 [A]  - Hong Kwangwon, Oh Kwangjun, Lee Siyoung, Hong Jaewoo, Choi Jida, Kwak Areum, Kang Dongjun, Kim Eunsom, Jo Seunghyun, Jhun Hyunjhung, Kim Soohyun, "Recombinant Fc-IL-18BPc Isoform Inhibits IL-18-Induced Cytokine Production", Hybridoma, US , (20120401), vol. 31, no. 2, doi:10.1089/hyb.2011.0085, ISSN 1554-0014, pages 99 - 104, XP055917055 [A] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1089/hyb.2011.0085
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.